Figure S2 from the CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP InhibitionKalindi Parmar,Bose Kochupurakkal,Jean‐Bernard Lazaro,Zhigang C. Wang,Sangeetha Palakurthi,Paul T. Kirschmeier, Chunyu Yang,Larissa A. Sambel,Anniina Färkkilä,Elizaveta Reznichenko,Hunter D. Reavis,Connor E. Dunn,Lee Zou,T. Khanh,Panagiotis A. Konstantinopoulos,Ursula A. Matulonis,Joyce F. Liu,Alan D. D’Andrea,Geoffrey I. Shapiroopenalex引用 0|浏览0暂无评分关键词PARP InhibitorsAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要